Post Hoc Analysis of a Previous Study of Estetrol 15 mg/Drospirenone 3 mg Combination for Dysmenorrhea and Uterine Bleeding in Adenomyosis Patients

Key Points

• Improvement in symptoms of dysmenorrhea and uterine bleeding was noted in patients with adenomyosis.
• The analysis highlights the effectiveness of a combination of estetrol 15 mg and drospirenone 3 mg treatments.
• Post hoc analysis based on a previous clinical study registered with the jRCT.
• Findings may influence treatment options for women suffering from adenomyosis-related symptoms.

Abstract